Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action
Open Access
- 1 June 2015
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 4 (6) , 350-361
Abstract
Chronic inflammation is associated with the development of human hepatocellular carcinoma (HCC), an essentially incurable cancer. Anti-inflammatory nutraceuticals have emerged as promising candidates against HCC, yet the mechanisms through which they influence the cell signaling machinery to impose phenotypic changes remain unresolved. Herein we implemented a systems biology approach in HCC cells, based on the integration of cytokine release and phospoproteomic data from high-throughput xMAP Luminex assays to elucidate the action mode of prominent nutraceuticals in terms of topology alterations of HCC-specific signaling networks. An optimization algorithm based on SigNetTrainer, an Integer Linear Programming formulation, was applied to construct networks linking signal transduction to cytokine secretion by combining prior knowledge of protein connectivity with proteomic data. Our analysis identified the most probable target phosphoproteins of interrogated compounds and predicted translational control as a new mechanism underlying their anticytokine action. Induced alterations corroborated with inhibition of HCC-driven angiogenesis and metastasis.Keywords
Funding Information
- John S. Latsis Public Benefit Foundation
- European Social Fund Plus
- European Regional Development Fund and General Secretariat for Research and Technology (09SYN-21-1078)
- German Federal Ministry of Education and Research (0315744)
This publication has 50 references indexed in Scilit:
- Drugging Wnt signalling in cancerThe EMBO Journal, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- Combined logical and data-driven models for linking signalling pathways to cellular responseBMC Systems Biology, 2011
- Chemokines as mediators of tumor angiogenesis and neovascularizationExperimental Cell Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Networks Inferred from Biochemical Data Reveal Profound Differences in Toll-like Receptor and Inflammatory Signaling between Normal and Transformed HepatocytesMolecular & Cellular Proteomics, 2010
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer and Metastasis Reviews, 2010
- Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transductionMolecular Systems Biology, 2009
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Nutraceutical-definition and introductionAAPS PharmSci, 2003